FibroScan

Curated by Signal

Provider of noninvasive devices for liver fibrosis and steatosis

Overview

Provider of noninvasive devices for liver fibrosis and steatosis. The company has developed devices based on a patented technology VCTE, Impulse Elastography Controlled Vibration that helps in the assessment of the stage of fibrosis in various chronic liver diseases. The company's products include FibroScan a non-invasive solution to manage liver health.

Key facts

Founded: 2005
Headquarters: Paris, France
Stage: Sign up to view
Industry: Life Sciences Technology

Business model

3 products and services: Sign up to view

Contact

Email: Sign up to view
Phone: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

Cardio Renal
Provider of digital therapeutics solutions for chronic kidney disease (CKD) management
Life Sciences TechnologyStrasbourg, France
X-Pressure
Provider of a medical device to measure cerebrospinal fluid pressure to diagnose brain diseases
Life Sciences TechnologyToulouse, France
Mayday SOS
Application based safety management platform provider
Life Sciences TechnologyMarseille, France

About FibroScan

What does FibroScan do?

Provider of noninvasive devices for liver fibrosis and steatosis.

Where is FibroScan headquartered?

FibroScan is headquartered in Paris, France.

When was FibroScan founded?

FibroScan was founded in 2005.

Which sector is FibroScan in?

FibroScan operates in Life Sciences Technology.

Who are FibroScan's competitors?

Companies similar to FibroScan include Cardio Renal, X-Pressure, and Mayday SOS.